639 related articles for article (PubMed ID: 25885285)
21. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
[TBL] [Abstract][Full Text] [Related]
22. SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL.
Cunha RB; Siqueira RC; Messias A; Scott IU; Fialho SL; Cunha-Junior ADS; Jorge R
Retin Cases Brief Rep; 2018 Winter; 12(1):50-58. PubMed ID: 27632583
[TBL] [Abstract][Full Text] [Related]
23. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
Ozkaya A; Tarakcioglu HN; Tanir I
Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion.
Harb W; Chidiac G; Harb G
Middle East Afr J Ophthalmol; 2021; 28(1):18-22. PubMed ID: 34321818
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
[TBL] [Abstract][Full Text] [Related]
26. EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION.
Bakri SJ; Omar AF; Iezzi R; Kapoor KG
Retina; 2016 Mar; 36(3):552-7. PubMed ID: 26418442
[TBL] [Abstract][Full Text] [Related]
27. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
28. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.
Chiquet C; Dupuy C; Bron AM; Aptel F; Straub M; Isaico R; Romanet JP; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2095-102. PubMed ID: 25673251
[TBL] [Abstract][Full Text] [Related]
30. Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion.
Augustin AJ; Holz FG; Haritoglou C; Mayer WJ; Bopp S; Scheuerle AF; Maier M; Sekundo W; Sandner D; Shirlaw A; Hattenbach LO
Ophthalmologica; 2015; 233(1):18-26. PubMed ID: 25503473
[TBL] [Abstract][Full Text] [Related]
31. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
32. Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant.
Busch C; Rehak M; Sarvariya C; Zur D; Iglicki M; Lima LH; Invernizzi A; Viola F; Agrawal K; Sinawat S; Couturier A; Mehta A; Juneja R; Jain H; Agarwal AK; Goel N; Nagpal M; Gupta V; Banker A; Loewenstein A; Okada M; Saatci AO; Mansour AM; Chhablani J
Br J Ophthalmol; 2019 Apr; 103(4):463-468. PubMed ID: 29891733
[TBL] [Abstract][Full Text] [Related]
33. Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion.
Iu LP; Zhao P; Yeung IY; Fung NS; Lee JW; Wong RL; Chong V; Wong IY
Br J Ophthalmol; 2015 Feb; 99(2):210-4. PubMed ID: 25138756
[TBL] [Abstract][Full Text] [Related]
34. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
Manousaridis K; Peter S; Mennel S
Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
[TBL] [Abstract][Full Text] [Related]
35. Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial.
Meng L; Yang M; Jiang X; Li Y; Han X
Int Ophthalmol; 2024 Jun; 44(1):262. PubMed ID: 38913192
[TBL] [Abstract][Full Text] [Related]
36. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone Intravitreal Implant Therapy for Retinal Vein Occlusion Macular Oedema and Conversion to Ranibizumab in Clinical Practice.
Balal S; Than J; Tekriwal S; Lobo A
Ophthalmologica; 2018; 239(1):36-44. PubMed ID: 28950262
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
Simsek M; Citirik M; Ozates S; Ozkoyuncu D
Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month follow-up and prognostic factors.
Maggio E; Polito A; Guerriero M; Pertile G
Ophthalmologica; 2014; 232(4):207-15. PubMed ID: 25471901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]